Skip to main content

Published locations for Baseline cardiovascular risk may influence MACE and malignancy incidences in tofacitinib-treated PsA patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Baseline cardiovascular risk may influence MACE and malignancy incidences in tofacitinib-treated PsA patients

User login

  • Reset your password
  • /content/baseline-cardiovascular-risk-may-influence-mace-and-malignancy-incidences-tofacitinib
  • /rheumatology/article/261201/psoriatic-arthritis/baseline-cardiovascular-risk-may-influence-mace-and
  • /psoriatic-arthritis-icymi/article/261201/psoriatic-arthritis/baseline-cardiovascular-risk-may